 Liver Neoplasms, Experimental
"Liver Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced tumors of the LIVER.
| Descriptor ID |
D008114
|
| MeSH Number(s) |
C04.588.274.623.460 C04.619.540 C06.301.623.460 C06.552.697.580 E05.598.500.496.750
|
| Concept/Terms |
Liver Neoplasms, Experimental- Liver Neoplasms, Experimental
- Experimental Liver Neoplasm
- Liver Neoplasm, Experimental
- Neoplasms, Experimental Liver
- Experimental Liver Neoplasms
Experimental Hepatoma- Experimental Hepatoma
- Hepatoma, Experimental
- Hepatomas, Experimental
- Experimental Hepatomas
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms, Experimental".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Site [C04.588]
- Digestive System Neoplasms [C04.588.274]
- Liver Neoplasms [C04.588.274.623]
- Liver Neoplasms, Experimental [C04.588.274.623.460]
- Neoplasms, Experimental [C04.619]
- Liver Neoplasms, Experimental [C04.619.540]
- Digestive System Diseases [C06]
- Digestive System Neoplasms [C06.301]
- Liver Neoplasms [C06.301.623]
- Liver Neoplasms, Experimental [C06.301.623.460]
- Liver Diseases [C06.552]
- Liver Neoplasms [C06.552.697]
- Liver Neoplasms, Experimental [C06.552.697.580]
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Investigative Techniques [E05]
- Models, Animal [E05.598]
- Disease Models, Animal [E05.598.500]
- Neoplasms, Experimental [E05.598.500.496]
- Liver Neoplasms, Experimental [E05.598.500.496.750]
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms, Experimental".
This graph shows the total number of publications written about "Liver Neoplasms, Experimental" by people in this website by year, and whether "Liver Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1985 | 1 | 0 | 1 | | 1986 | 1 | 0 | 1 | | 1987 | 1 | 0 | 1 | | 1988 | 1 | 0 | 1 | | 1989 | 1 | 0 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 1 | 0 | 1 | | 1994 | 0 | 1 | 1 | | 1995 | 0 | 1 | 1 | | 1996 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 0 | 2 | 2 | | 1999 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2002 | 2 | 0 | 2 | | 2003 | 1 | 0 | 1 | | 2005 | 2 | 1 | 3 | | 2006 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Liver Neoplasms, Experimental" by people in Profiles.
-
McClendon AK, Dean JL, Ertel A, Fu Z, Rivadeneira DB, Reed CA, Bourgo RJ, Witkiewicz A, Addya S, Mayhew CN, Grimes HL, Fortina P, Knudsen ES. RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage. Gastroenterology. 2011 Oct; 141(4):1439-50.
-
Lacoeuille F, Hindre F, Moal F, Roux J, Passirani C, Couturier O, Cales P, Le Jeune JJ, Lamprecht A, Benoit JP. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int J Pharm. 2007 Nov 01; 344(1-2):143-9.
-
Moran DM, Koniaris LG, Jablonski EM, Cahill PA, Halberstadt CR, McKillop IH. Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression. Cell Transplant. 2006; 15(8-9):785-98.
-
Thirunavukkarasu C, Premkumar K, Jagadeeswaran R, Sakthisekaran D. The inhibitory effect of sodium selenite on N-nitrosodiethylamine-induced and phenobarbital promoted liver tumourigenesis in rats based on the modulation of polyamine levels. Mol Cell Biochem. 2005 Dec; 280(1-2):165-72.
-
Garin E, Denizot B, Roux J, Noiret N, Lepareur N, Moreau M, Mesba A, Laurent JF, Herry JY, Bourguet P, Benoit JP, Lejeune JJ. Effect of stabilized iodized oil emulsion on experimentally induced hepatocellular carcinoma in rats. J Vasc Interv Radiol. 2005 Jun; 16(6):841-8.
-
Moran DM, Mayes N, Koniaris LG, Cahill PA, McKillop IH. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Liver Int. 2005 Apr; 25(2):445-57.
-
Lee L, Sudentas P, Donohue B, Asrican K, Worku A, Walker V, Sun Y, Schmidt K, Albert MS, El-Hashemite N, Lader AS, Onda H, Zhang H, Kwiatkowski DJ, Dabora SL. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer. 2005 Mar; 42(3):213-27.
-
Zhou J, Tang ZY, Fan J, Wu ZQ, Ji Y, Xiao YS, Shi YH, Li XM, Sun QM, Liu YK, Ye SL. Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):6030-7.
-
McCrudden KW, Yokoi A, Thosani A, Soffer SZ, Kim ES, Huang J, Manley C, O'toole K, Yamashiro DJ, Kandel JJ, Middlesworth W. Topotecan is anti-angiogenic in experimental hepatoblastoma. J Pediatr Surg. 2002 Jun; 37(6):857-61.
-
Chung SM, Advani SJ, Bradley JD, Kataoka Y, Vashistha K, Yan SY, Markert JM, Gillespie GY, Whitley RJ, Roizman B, Weichselbaum RR. The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma. Gene Ther. 2002 Jan; 9(1):75-80.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|